Mode
Text Size
Log in / Sign up
N/A N=832 Triple-blind Health Services Research

Enhancing Community Capacity to Improve Cancer Care Delivery

End of Life · Cancer

Enrolled (actual)
832
Serious AEs
0.0%
Results posted
Feb 2025
Primary outcome: Primary: Edmonton Symptom Assessment Scale (ESAS) Symptom Screen — 7; 7 total score on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Program participants (Behavioral); Usual Care (Other)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Stanford University
Primary completion
Sep 2020

Outcome Measures

OutcomeResultp-value
PRIMARY
Edmonton Symptom Assessment Scale (ESAS) Symptom Screen
7; 9.8
PRIMARY
Edmonton Symptom Assessment Scale (ESAS) Symptom Screen
7; 9.8
PRIMARY
Edmonton Symptom Assessment Scale (ESAS) Symptom Screen
7; 9.8
PRIMARY
Personal Health Questionnaire-9 (PHQ-9) Depression Screen
1.9; 3.9
PRIMARY
Personal Health Questionnaire-9 (PHQ-9) Depression Screen
1.9; 3.9
PRIMARY
Personal Health Questionnaire-9 (PHQ-9) Depression Screen
1.9; 3.9
SECONDARY
Incidence of Emergency Department Visits Within 12-months After Patient Enrollment (Chart Review)
0.43; 0.57
SECONDARY
Incidence of Hospitalization Visits Within 12 Months After Patient Enrollment (Chart Review)
0.54; 0.72
SECONDARY
Number of Patients With a Hospice Consult Within 12-months After Patient Enrollment (Chart Review)
207; 101
SECONDARY
Total Health Care Costs (Claims Review)
17,869; 18,473
SECONDARY
Number of Patients With an Acute Care Facility Death (Chart Review)
18; 30
SECONDARY
Number of Emergency Department Visit in the Last 30 Days of Life (Chart Review)
0.10; 0.30
SECONDARY
Number of Hospitalization Visits in the Last 30 Days of Life (Chart Review)
0.27; 0.43
SECONDARY
Number of Patients With a Hospice Consult in the Last 30 Days of Life (Chart Review)
125; 79
SECONDARY
Total Costs of Care (Claims Review)
3,602; 12,726

Summary

Undertreated patient symptoms and resulting acute care use require approaches that improve symptom-burden. Previously a a lay health worker (LHW)-led symptom screening intervention was developed for patients with advanced cancer. This intervention will be expanded to all patients with cancer and the LHW will be trained to refer patients to palliative care and behavioral health. This intervention will evaluate the effect on symptom-burden, survival, healthcare use, and total costs.

Eligibility Criteria

Inclusion Criteria

  • Newly diagnosed with cancer
  • Diagnosis of relapse or progressive disease (any cancer diagnosis) as identified by imaging or biopsy and confirmed by physician.
  • Must be 18 years or older.
  • Must have capacity to verbally consent

Exclusion Criteria

-Inability to consent to the study due to lack of capacity as documented by the referring physician.

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04107116). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search